NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.1 Cytotoxic drugs > 8.1.4 Vinca alkaloids and etoposide > Urothelial tract carcinoma (transitional cell, advanced, metastatic) – vinflunine - NICE TAG TA272

Urothelial tract carcinoma (transitional cell, advanced, metastatic) – vinflunine - NICE TAG TA272

1.1 Vinflunine is not recommended within its marketing authorisation for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract that has progressed after treatment with platinum-based chemotherapy.

1.2 People currently receiving vinflunine that is not recommended according to 1.1 should be able to continue treatment until they and their clinician consider it appropriate to stop.

https://www.nice.org.uk/guidance/TA272

 

Site by Devopa
© Copyright 2019 NHS. All rights reserved.